Gout: The Impact of Niacin on Uric Acid Levels
Gout, a form of inflammatory arthritis, is caused by the accumulation of uric acid crystals in the joints. Recent studies have revealed a potential link between niacin and the development of gout. Niacin, also known as vitamin B3, has been found to inhibit uricase, an enzyme responsible for metabolizing uric acid in the liver. This inhibition can result in a slowed metabolism of uric acid, leading to its build-up in the bloodstream and an increased risk of gout.
Rhabdomyolysis: Muscle Breakdown and its Link to Statin Medications
Rhabdomyolysis is a condition characterized by the breakdown of muscle fibers, leading to the release of proteins and other substances into the bloodstream. Although rare, this condition can be a potential side effect of statin medications, which are commonly prescribed to control cholesterol levels. While mild muscle soreness is a known side effect of statin therapy, severe muscle pain may indicate a more serious issue such as muscle breakdown.
It is important to note that the risk of developing rhabdomyolysis can increase when statins are combined with niacin, another medication used to manage cholesterol levels. The combination therapy of statins and niacin should be carefully monitored to minimize the risk of this condition.